Nisa Investment Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$39M Sell
1,389,916
-104,032
-7% -$2.77M 0.14% 88
2025
Q4
$37.2M Buy
1,493,948
+121,960
+9% +$3.08M 0.12% 94
2025
Q3
$35M Buy
1,371,988
+5,724
+0.4% +$141K 0.13% 98
2025
Q2
$33.1M Sell
1,366,264
-4,028
-0.3% -$93.9K 0.15% 110
2025
Q1
$34.7M Sell
1,370,292
-354,629
-21% -$9.28M 0.17% 103
2024
Q4
$45.8M Sell
1,724,921
-17,422
-1% -$473K 0.18% 84
2024
Q3
$50.4M Buy
1,742,343
+118,473
+7% +$3.46M 0.3% 65
2024
Q2
$45.4M Buy
1,623,870
+22,798
+1% +$628K 0.29% 64
2024
Q1
$44.4M Sell
1,601,072
-83,283
-5% -$2.31M 0.29% 67
2023
Q4
$48.5M Buy
1,684,355
+42,035
+3% +$1.27M 0.34% 55
2023
Q3
$54.5M Sell
1,642,320
-127,195
-7% -$4.5M 0.42% 42
2023
Q2
$64.9M Buy
1,769,515
+37,416
+2% +$1.46M 0.48% 38
2023
Q1
$70.7M Sell
1,732,099
-29,597
-2% -$1.28M 0.55% 28
2022
Q4
$90.3M Sell
1,761,696
-59,224
-3% -$2.84M 0.71% 16
2022
Q3
$79.8M Buy
1,820,920
+35,216
+2% +$1.71M 0.68% 19
2022
Q2
$93.6M Buy
1,785,704
+19,483
+1% +$993K 0.82% 15
2022
Q1
$91.4M Sell
1,766,221
-59,505
-3% -$3.09M 0.64% 20
2021
Q4
$96.2M Buy
1,825,726
+63,892
+4% +$3.17M 0.72% 20
2021
Q3
$75.8K Sell
1,761,834
-16,200
-0.9% -$718K 0.46% 34
2021
Q2
$69.6K Sell
1,778,034
-238,240
-12% -$9.26M 0.43% 37
2021
Q1
$73K Sell
2,016,274
-161,600
-7% -$5.74M 0.46% 35
2020
Q4
$80.2M Sell
2,177,874
-129,484
-6% -$4.75M 0.52% 31
2020
Q3
$80.3M Buy
2,307,358
+47,989
+2% +$1.68M 0.65% 27
2020
Q2
$70.1M Sell
2,259,369
-23,580
-1% -$801K 0.64% 27
2020
Q1
$70.7M Sell
2,282,949
-77,996
-3% -$2.66M 0.79% 21
2019
Q4
$87.8M Sell
2,360,945
-66,903
-3% -$2.38M 0.75% 22
2019
Q3
$82.8M Sell
2,427,848
-25,329
-1% -$921K 0.73% 24
2019
Q2
$101M Sell
2,453,177
-68,488
-3% -$2.72M 0.96% 16
2019
Q1
$102M Sell
2,521,665
-137,547
-5% -$5.51M 0.99% 15
2018
Q4
$110M Buy
2,659,212
+55,862
+2% +$2.32M 1.23% 8
2018
Q3
$109M Buy
2,603,350
+61,765
+2% +$2.38M 0.99% 12
2018
Q2
$87.5M Buy
2,541,585
+84,802
+3% +$2.9M 0.9% 17
2018
Q1
$83.1M Sell
2,456,783
-76,310
-3% -$2.62M 0.87% 19
2017
Q4
$87M Sell
2,533,093
-39,371
-2% -$1.34M 0.9% 19
2017
Q3
$87.1M Buy
2,572,464
+41,279
+2% +$1.33M 0.98% 14
2017
Q2
$80.3M Sell
2,531,185
-77,789
-3% -$2.45M 0.94% 15
2017
Q1
$84.7M Buy
2,608,974
+99,224
+4% +$3.13M 1.01% 13
2016
Q4
$77.3M Sell
2,509,750
-137,503
-5% -$4.2M 0.94% 15
2016
Q3
$85.1M Buy
2,647,253
+16,760
+0.6% +$560K 1.1% 10
2016
Q2
$87.9M Buy
2,630,493
+285,663
+12% +$9.12M 1.18% 7
2016
Q1
$65.9M Sell
2,344,830
-90,512
-4% -$2.59M 0.95% 13
2015
Q4
$74.6M Sell
2,435,342
-56,916
-2% -$1.79M 1.07% 11
2015
Q3
$74.4M Buy
2,492,258
+4,304
+0.2% +$138K 1.14% 10
2015
Q2
$79.1M Buy
2,487,954
+67,185
+3% +$2.19M 1.12% 10
2015
Q1
$79.9M Sell
2,420,769
-17,258
-0.7% -$549K 1.1% 9
2014
Q4
$72.1M Sell
2,438,027
-270,923
-10% -$7.77M 0.99% 12
2014
Q3
$76M Buy
2,708,950
+4,743
+0.2% +$133K 1.07% 12
2014
Q2
$76.2M Sell
2,704,207
-138,212
-5% -$3.94M 1.06% 11
2014
Q1
$86.6M Sell
2,842,419
-63,107
-2% -$1.88M 1.23% 10
2013
Q4
$84.4M Sell
2,905,526
-124,932
-4% -$3.64M 1.21% 10
2013
Q3
$82.6M Sell
3,030,458
-145,900
-5% -$3.97M 1.26% 10
2013
Q2
$84.4M Buy
+3,176,358
New +$87.8M 1.31% 9

Other funds holding PFE

Nisa Investment Advisors's PFE Position: Q1 2026 in Review

Nisa Investment Advisors reduced its Pfizer (PFE) stake by 7% in Q1 2026, selling an estimated $2.77M and leaving 1,389,916 shares worth $39M. The position accounts for 0.14% of the portfolio, ranked #88.

Nisa Investment Advisors first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $110M in Q4 2018. 2,946 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Nisa Investment Advisors held 1,389,916 shares of Pfizer worth $39M as of Q1 2026.
  • Nisa Investment Advisors sold 104,032 Pfizer shares in Q1 2026, an estimated $2.77M.
  • Pfizer made up 0.14% of Nisa Investment Advisors's portfolio in Q1 2026, its #88 holding.
  • Nisa Investment Advisors first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Nisa Investment Advisors's Pfizer position peaked at $110M in Q4 2018.
  • 2,946 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.